Biomarker of active pulmonary tuberculosis, and application of biomarker
A technology for active pulmonary tuberculosis and biomarkers, which is applied in the field of biomarkers to achieve the effects of convenient collection, easy handling and economic burden reduction
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0040] A biomarker of active pulmonary tuberculosis in this embodiment, see figure 1 , the biomarker is hsa-miR-433-3p.
[0041] Among them, the expression of hsa-miR-433-3p is significantly upregulated in APTB PBMCs, see for details figure 1 Shown in Figure A.
[0042] Among them, the hsa-miR-433-3p indicates early active pulmonary tuberculosis.
[0043] In this example, the up-regulated hsa-miR-433-3p is of great significance for the early diagnosis of APTB patients. Therefore, detecting the expression level of hsa-miR--433-3p in APTB patients by qPCR method can diagnose the disease, and then confirm that the hsa-miR-433-3p can be used to prepare active tuberculosis diagnostic reagents.
Embodiment 2
[0045] For the application of a biomarker for active pulmonary tuberculosis in this embodiment, see figure 1 and figure 2, the hsa-miR-433-3p in Example 1 was applied to the preparation of a diagnostic reagent for active pulmonary tuberculosis.
[0046] Compared with the existing detection techniques such as sputum smear microscopy and sputum culture, the active tuberculosis diagnostic reagent prepared by using the hsa-miR-433-3p has the following advantages: the collection of peripheral blood samples is convenient, and the peripheral blood samples are easy to obtain. Processing; the detection time is short, and the result can be obtained quickly, which is conducive to the rapid diagnosis of the disease; the detection cost is relatively low, which can reduce the economic burden of the patient.
Embodiment 3
[0048] For the application of a biomarker for active pulmonary tuberculosis in this embodiment, see Figure 2-4 , using hsa-miR-433-3p in Example 1 as a therapeutic target for active pulmonary tuberculosis. Using hsa-miR-433-3p as a therapeutic target for APTB is beneficial to the development of new drugs.
[0049] Among them, the potential downstream target genes of hsa-miR-433-3p are Rap1a and PDCD4.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com